The Effect of Electronic-Cigarette Vaping on Cardiac Function and Angiogenesis in Mice

Scientific Reports

Volumn 9, Issue 1, 2019, Pages

  Shi, Huilin ^a   Fan, Xiaoming ^a   Horton, Austin ^a   Haller, Steven T ^a   Kennedy, David J ^a   Schiefer, Isaac T ^a   Dworkin, Lance ^a   Cooper, Christopher J ^a   Tian, Jiang ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1;

ADVERSE EVENT; ANIMAL; BODY WEIGHT GAIN; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG EFFECT; ECHOCARDIOGRAPHY; ELECTRONIC CIGARETTE; FEMALE; GENETICS; HEART CONTRACTION; HEART FUNCTION TEST; HUMAN; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; VAPING;

ANIMALS; ANTIGENS, CD34; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HEART FUNCTION TESTS; HUMANS; MALE; MICE; MYOCARDIAL CONTRACTION; NEOVASCULARIZATION, PATHOLOGIC; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1; VAPING; WEIGHT GAIN;

EID: 85062765655     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-019-40847-5     Document Type: Article

References (39)

1. Conard, M. W., Haddock, C. K., Poston, W. S. & Spertus, J. A. & Cardiovascular Outcomes Research, C. The impact of smoking status on the health status of heart failure patients. Congest Heart Fail 15, 82–86, 10.1111/j.1751-7133.2009.00053.x (2009).
2. Gopal, D. M. et al. Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study. Am Heart J 164, 236–242, 10.1016/j.ahj.2012.05.013 (2012).
3. Jay, S. J. Smoking is an important component in the analysis of heart failure. Arch Intern Med 159, 2225–2226 (1999).
4. Nicolozakes, A. W., Binkley, P. F. & Leier, C. V. Hemodynamic effects of smoking in congestive heart failure. Am J Med Sci 296, 377–380 (1988).
5. Plank, B. et al. Smoking is associated with an increased risk of first and recurrent ventricular tachyarrhythmias in ischemic and nonischemic patients with mild heart failure: a MADIT-CRT substudy. Heart Rhythm 11, 822–827, 10.1016/j.hrthm.2014.02.007 (2014).
6. Shah, A. M. et al. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. Am J Cardiol 106, 911–916, 10.1016/j.amjcard.2010.05.021 (2010).
7. Hammett, E., Veldheer, S., Yingst, J., Hrabovsky, S. & Foulds, J. Characteristics, use patterns and perceptions of electronic cigarette users who were never traditional cigarette smokers. Addict Behav 65, 92–97, 10.1016/j.addbeh.2016.10.007 (2017).
8. Gorukanti, A., Delucchi, K., Ling, P., Fisher-Travis, R. & Halpern-Felsher, B. Adolescents’ attitudes towards e-cigarette ingredients, safety, addictive properties, social norms, and regulation. Prev Med 94, 65–71, 10.1016/j.ypmed.2016.10.019 (2017).
9. Etu, E. S., Gemeda, D. H. & Hussen, M. A. Prevalence and factors that influence smokeless tobacco use among adults in pastoralist communities of Borena Zone, Ethiopia: mixed method study. Tob Induc Dis 15, 1, 10.1186/s12971-016-0106-7 (2017).
10. Dai, H. & Hao, J. Electronic cigarette and marijuana use among youth in the United States. Addict Behav 66, 48–54, 10.1016/j.addbeh.2016.11.005 (2017).
11. Brikmanis, K., Petersen, A. & Doran, N. E-Cigarette Use, Perceptions, and Cigarette Smoking Intentions in a Community Sample of Young Adult Nondaily Cigarette Smokers. Psychol Addict Behav, 10.1037/adb0000257 (2017).
12. Carr, E. R. E-cigarettes: facts, perceptions, and marketing messages. Clinical journal of oncology nursing 18, 112–116, 10.1188/14.cjon.112-116 (2014).
13. De Marco, C. et al. The electronic cigarette: potential health benefit or mere business? Tumori 99, 299e–301e, 10.1700/1390.15473 (2013).
14. Hampton, T. Experts call for research plus regulation of e-cigarettes. JAMA 311, 123–124, 10.1001/jama.2013.285292 (2014).
15. Jo, C. L. et al. US consumer interest in non-cigarette tobacco products spikes around the 2009 federal tobacco tax increase. Tob Control, 10.1136/tobaccocontrol-2013-051261 (2014).
16. Doyle, C., Patterson, S. & Scott, J. Electronic cigarettes and smoking cessation: a quandary? Lancet 383, 408, 10.1016/s0140-6736(14)60145-8 (2014).
17. Lee, Y. O., Hebert, C. J., Nonnemaker, J. M. & Kim, A. E. Multiple tobacco product use among adults in the United States: Cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus. Prev Med, 10.1016/j.ypmed.2014.01.014 (2014).
18. Farsalinos, K. E., Tsiapras, D., Kyrzopoulos, S., Savvopoulou, M. & Voudris, V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord 14, 78, 10.1186/1471-2261-14-78 (2014).
19. Farsalinos, K. E. et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 10, 5146–5162, 10.3390/ijerph10105146 (2013).
20. Teasdale, J. E., Newby, A. C., Timpson, N. J., Munafo, M. R. & White, S. J. Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture. Drug Alcohol Depend 163, 256–260, 10.1016/j.drugalcdep.2016.04.020 (2016).
21. Taylor, M. et al. E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol Mech Methods 26, 465–476, 10.1080/15376516.2016.1222473 (2016).
22. Goniewicz, M. L. et al. Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study. Nicotine Tob Res 19, 160–167, 10.1093/ntr/ntw160 (2017).
23. Wang, P. et al. A Device-Independent Evaluation of Carbonyl Emissions from Heated Electronic Cigarette Solvents. PLoS One 12, e0169811, 10.1371/journal.pone.0169811 (2017).
24. Javed, F., Kellesarian, S. V., Sundar, I. K., Romanos, G. E. & Rahman, I. Recent updates on electronic cigarette aerosol and inhaled nicotine effects on periodontal and pulmonary tissues. Oral Dis, 10.1111/odi.12652 (2017).
25. Moheimani, R. S. et al. Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk. JAMA Cardiol, 10.1001/jamacardio.2016.5303 (2017).
26. Crotty Alexander, L. E. et al. Chronic Inhalation of E-Cigarette Vapor Containing Nicotine Disrupts Airway Barrier Function and Induces Systemic Inflammation and Multi-Organ Fibrosis in Mice. Am J Physiol Regul Integr Comp Physiol, 10.1152/ajpregu.00270.2017 (2018).
27. Drummond, C. A. et al. Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis. PLoS One 12, e0173562, 10.1371/journal.pone.0173562 (2017).
28. Drummond, C. A. et al. Cigarette smoking causes epigenetic changes associated with cardiorenal fibrosis. Physiol Genomics 48, 950–960, 10.1152/physiolgenomics.00070.2016 (2016).
29. Jain, R. K. Clearing the smoke on nicotine and angiogenesis. Nat Med 7, 775–777, 10.1038/89889 (2001).
30. Ejaz, S. & Lim, C. W. Toxicological overview of cigarette smoking on angiogenesis. Environ Toxicol Pharmacol 20, 335–344, 10.1016/j.etap.2005.03.011 (2005).
31. Hwang, J. H. et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. Journal of molecular medicine (Berlin, Germany), 10.1007/s00109-016-1378-3 (2016).
32. Drummond, C. A. et al. Gender Differences in the development of uremic cardiomyopathy following partial nephrectomy: Role of progesterone. Journal of Hypertension: Open Access 2, 109–117, 10.4172/2167-1095.1000109 (2013).
33. Haller, S. T. et al. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. American journal of hypertension 25, 690–696, 10.1038/ajh.2012.17 (2012).
34. Kennedy, D. J. et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47, 488–495 (2006).
35. Morgan, E. E. et al. Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. American journal of physiology. Heart and circulatory physiology 287, H2049–2053, 10.1152/ajpheart.00393.2004 (2004).
36. Morgan, E. E., Casabianca, A. B., Khouri, S. J. & Kalinoski, A. L. In vivo assessment of arterial stiffness in the isoflurane anesthetized spontaneously hypertensive rat. Cardiovascular ultrasound 12, 37, 10.1186/1476-7120-12-37 (2014).
37. Drummond, C. A. et al. Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice. Am J Physiol Heart Circ Physiol 306, H1631–1643, 10.1152/ajpheart.00102.2014 (2014).
38. Kennedy, D. J. et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol 294, F450–454, 10.1152/ajprenal.00472.2007 (2008).
39. Alasmari, F. et al. Effects of chronic inhalation of electronic cigarettes containing nicotine on glial glutamate transporters and alpha-7 nicotinic acetylcholine receptor in female CD-1 mice. Prog Neuropsychopharmacol Biol Psychiatry 77, 1–8, 10.1016/j.pnpbp.2017.03.017 (2017).